SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001387131-22-005742
Filing Date
2022-05-05
Accepted
2022-05-05 16:04:04
Documents
1
Group Members
ATLAS VENTURE ASSOCIATES XII, L.P.ATLAS VENTURE ASSOCIATES XII, LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM SC 13D aerovate-sc13da_040122.htm SC 13D/A 52915
  Complete submission text file 0001387131-22-005742.txt   54545
Mailing Address 200 BERKELEY STREET FLOOR 18 BOSTON MA 02116
Business Address 200 BERKELEY STREET FLOOR 18 BOSTON MA 02116 617-443-2400
Aerovate Therapeutics, Inc. (Subject) CIK: 0001798749 (see all company filings)

IRS No.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92668 | Film No.: 22896106
SIC: 2834 Pharmaceutical Preparations

Mailing Address 400 TECHNOLOGY SQUARE 10TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 10TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Atlas Venture Fund XII, L.P. (Filed by) CIK: 0001812049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A